2023 Advisory Committee - BIO CEO & Investor Conference

Janice Bourque, Managing Director, Life Sciences, Hercules Capital

Jennifer Cochran, Shriram Chair of the Department of Bioengineering, Stanford University

Brian Cook, Executive Director, Transactions, Bristol Myers Squibb

Michelle Doig, Partner, Head of Corporate Development, Omega Funds

Jack Florio, Managing Director, Weild & Co.

Chris Garabedian, Chairman & CEO, Xontogeny

Kate Haviland, CEO, Blueprint Medicines

Jennifer Hawks Bland, CEO, NewYorkBIO

Anna Kazanchyan, MD, Chairwoman and CEO, Saghmos Therapeutics

Guido Lanza, Vice President, Integrated Research, Valo Health

Evan Loh, MD, CEO, Paratek

Glennis Mehra, PhD, Director, BioLabs New York

Sara Nayeem, MD, Partner, Avoro Ventures

Kimberly Nearing, Venture Partner, BVCF

Dennis Purcell, Founder and Senior Advisor, Aisling Capital

Stephen M. Ritoch, Chairman of the Board and Chief Executive Officer, Blaise Group International, Inc. (BGI)

Philip Ross, Global Chairman, Healthcare Investment Banking, J.P. Morgan

Sandor Schoichet, Co-Founder and Partner, Biopharma Sustainability Roundtable

Mahendra Shah, Managing Director, Vivo Capital

Jennifer Sheng, Managing Director, Citi

Takaaki Tobaru, Partner, Remiges Ventures

Michael Ward, Vice President, Public Policy, Alliance for Aging Research